The DOI matches its Crossref record.
Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with clinical trials with similar follow-up, outcomes were favorable, including: 9% hernia recurrence, 9% SSI, and 6% seroma.”
From Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up (2021) · cites this paper as [8]
In the citing paper
“To date, long-term clinical outcomes associated with P4HB mesh have not been reported beyond these 18–24 month studies, possibly due to the high costs associated with conducting a long-term clinical trial.”
From Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up (2021) · cites this paper as [8]
In the citing paper
“In the 18-month reporting of the current trial, P4HB mesh was utilized to perform VIHR in 121 subjects [8].”
From Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up (2021) · cites this paper as [8]
In the citing paper
“Consistent with clinical trials with similar follow-up, outcomes were favorable, including: 9% hernia recurrence, 9% SSI, and 6% seroma.”
From Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up (2021) · cites this paper as [8]
In the citing paper
“Consistent with clinical trials with similar follow-up, outcomes were favorable, including: 9% hernia recurrence, 9% SSI, and 6% seroma.”
From Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 26
- Cox TC, Blair LJ, Huntington CR, Colavita PD, Prasad T, Lincourt AE, Heniford BT, Augenstein VA (2016) The cost of preventable comorbidities on wound complications in open ventral hernia repair. J Surg Res 206:214–222 · DOI
- Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT (2005) Predictors of wound infection in ventral hernia repair. Am J Surg 190:676–681 · DOI · Paper page
- Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, Kilbridge JF, Rosen M, Silverman RP, Vargo D (2010) Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 148:544–558 · DOI
- Jin J, Rosen MJ, Blatnik J, Mcgee MF, Williams CP, Marks J, Ponsky J (2007) Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg 205:654–660 · DOI
- Itani KM, Rosen M, Vargo D, Awad SS, Denoto G 3rd, Butler CE, Group RS (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study. Surgery 152:498–505 · DOI · Paper page
- Helgstrand F, Rosenberg J, Kehlet H, Jorgensen LN, Bisgaard T (2013) Nationwide prospective study of outcomes after elective incisional hernia repair. J Am Coll Surg 216:217–228 · DOI · Paper page
- Rosen M, Bauer J, Harmaty M, Carbonell AM, Cobb WS, Matthews BD, Goldblatt M, Selzer D, Poulose BK, Hansson BM, Rosman C, Chao J, Jacobsen G (2017) Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the COBRA Study. Ann Surg 265:205–211 · DOI · Paper page
- Bansal VK, Misra MC, Kumar S, Keerthi RY, Singhal P, Goswami A, Guleria S, Arora MK, Chabra A (2011) A prospective randomized study comparing suture mesh fixation versus tacker mesh fixation for laparoscopic repair of incisional and ventral hernias. Surg Endosc 25:1431–1438 · DOI
- Reynvoet E, Deschepper E, Rogiers X, Troisi R, Berrevoet F (2014) Laparoscopic ventral hernia repair: is there an optimal mesh fixation technique? A systematic review. Langenbecks Arch Surg 399:55–63 · DOI
- Rosen MJ, Krpata DM, Ermlich B, Blatnik JA (2013) A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg 257:991–996 · DOI
- Primus FE, Harris HW (2013) A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions. Hernia 17:21–30 · DOI
- Rosen MJ (2010) Biologic mesh for abdominal wall reconstruction: a critical appraisal. Am Surg 76:1–6 · DOI
- Slater NJ, Van Der Kolk M, Hendriks T, Van Goor H, Bleichrodt RP (2013) Biologic grafts for ventral hernia repair: a systematic review. Am J Surg 205:220–230 · DOI
- Jenkins ED, Yip M, Melman L, Frisella MM, Matthews BD (2010) Informed consent: cultural and religious issues associated with the use of allogeneic and xenogeneic mesh products. J Am Coll Surg 210:402–410 · DOI
- Deeken CR, Matthews BD (2013) Characterization of the mechanical strength, resorption properties, and histologic characteristics of a fully absorbable material (poly-4-hydroxybutyrate-PHASIX Mesh) in a porcine model of hernia repair. ISRN Surg 2013:238067 · DOI · Paper page
- Martin DP, Badhwar A, Shah DV, Rizk S, Eldridge SN, Gagne DH, Ganatra A, Darois RE, Williams SF, Tai HC, Scott JR (2013) Characterization of poly-4-hydroxybutyrate mesh for hernia repair applications. J Surg Res 184:766–773 · DOI · Paper page
- Scott JR, Deeken CR, Martindale RG, Rosen MJ (2016) Evaluation of a fully absorbable poly-4-hydroxybutyrate/absorbable barrier composite mesh in a porcine model of ventral hernia repair. Surg Endosc 30:3691–3701 · DOI
- Mangram A, Horan T, Pearson M, Silver L, Jarvis W (2014) Guideline for prevention of surgical site infection, 1999. Am J Infect Control 20:250–280
- Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583 · DOI · Paper page
- Kokotovic D, Bisgaard T, Helgstrand F (2016) Long-term recurrence and complications associated with elective incisional hernia repair. JAMA 316:1575–1582 · DOI · Paper page
- Totten CF, Davenport DL, Ward ND, Roth JS (2016) Cost of ventral hernia repair using biologic or synthetic mesh. J Surg Res 203:459–465 · DOI
- Roth JS, Zachem A, Plymale MA, Davenport DL (2017) Complex ventral hernia repair with acellular dermal matrices: clinical and quality of life outcomes. Am Surg 83:141–147 · DOI
- Chamieh J, Tan WH, Ramirez R, Nohra E, Apakama C, Symons W (2017) Synthetic versus biologic mesh in single-stage repair of complex abdominal wall defects in a contaminated field. Surg Infect 18:112–118 · DOI
- Atema JJ, De Vries FE, Boermeester MA (2016) Systematic review and meta-analysis of the repair of potentially contaminated and contaminated abdominal wall defects. Am J Surg 212:982–995 e981 · DOI
- Carbonell AM, Criss CN, Cobb WS, Novitsky YW, Rosen MJ (2013) Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg 217:991–998 · DOI · Paper page
- Plymale MA, Ragulojan R, Davenport DL, Roth JS (2017) Ventral and incisional hernia: the cost of comorbidities and complications. Surg Endosc 31:341–351 · DOI
Cited by
Roth, J. S., Anthone, G. J., Selzer, D. J., Poulose, B. K., Pierce, R. A., Bittner, J. G., Hope, W. W., Dunn, R. M., Martindale, R. G., Goldblatt, M. I., et al. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.12.002 · Cited by 40
Self-citation
Metadata
- Authors
- Roth, J. S., Anthone, G. J., Selzer, D. J., Poulose, B. K., Bittner, J. G., Hope, W. W., Dunn, R. M., Martindale, R. G., Goldblatt, M. I., Earle, D. B., Romanelli, J. R., Mancini, G. J., Greenberg, J. A., Linn, J. G., Parra-Davila, E., Sandler, B. J., Deeken, C. R., & Voeller, G. R.
- Venue
- Surgical Endoscopy
- Published
- 2017-10-23
- Volume
- 32
- Issue
- 4
- Pages
- 1929-1936
- ISSN
- 0930-2794
- 1432-2218
- Cited by
- 76
- References
- 0
- Language
- en
- Funders
- C. R. Bard, Inc. (Davol)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.